NYSE:QGENLife Sciences
Qiagen (QGEN) Stock Could Be A Cash Flow Bargain Yet Fair On Earnings
Qiagen has delivered a roughly 20% decline over the past five years, yet the current share price around US$41.40 sits at a discount to its intrinsic value estimate from a Discounted Cash Flow (DCF) model, while market based multiples suggest the stock is closer to fairly valued. That mix leaves investors weighing a model that points to upside against a track record of weak long term returns.
Over five years, Qiagen shares are down about 20%, which suggests the market has been cautious on the...